With the popularity of AI coding tools rising among some software developers, their adoption has begun to touch every aspect ...

Skills—a capability that allows users to teach Claude repeatable workflows—was introduced in October, and now Anthropic is ...

Morgan Stanley recently projected a US power shortfall through 2028, totaling 45 gigawatts (20% of total data center demand), ...

Recursion Pharmaceuticals ( RXRX +1.91%) was in the headlines on Monday, and for the right reason. One of the biotech company ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Need a better way to plan projects? Discover mind map examples that help you visually organize tasks, ideas, and strategies ...

How BioRender and CEO Shiz Aoki are turning a standard visual language for biology into must-have AI infrastructure, from ...

Current AI models fail to recognize 'relational' image similarities, such as how the Earth’s layers are similar to a peach, ...